Effects of Atorvastatin and Gemfibrozil on Mice Corpus Cavernosum, in vitro
Preprint
- 24 June 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Most of the drugs used in the treatment of cardiovascular diseases cause unfavourable effects on erectile functions. In this study, the effect of atorvastatin and gemfibrozil, which has different hypolipidemic mechanisms of action, on the erectile functions observed in mouse corpus cavernosum tissues are evaluatedin vitro. Mouse corpus cavernosum tissues are dissected under ketamine and xylazine anesthesia. Vessels were suspended in 30 ml organ baths filled with Krebs solution and aerated with carbogen (95% O2, 5% CO2) at 37°C. A initial tension of 500 mg was applied to the suspended tissue strips. After a stabilisation period of 90 minutes, the protocols were applied to the tissue. Atorvastatin and gemfibrozil showed no direct contractile or relaxant effect on corpus cavernosum tissues. Both drugs caused a dose –dependent relaxation in tissues precontracted with phenylephrine. While the relaxant effect of atorvastatin is inhibited 40% by L-NAME, this relaxations are totally inhibited by atropine. The relaxations caused by gemfibrozil are inhibited both by L-NAME and atropine. No change was observed in responses of the tissues to acethylcholine, nitroprusside and electrical field stimulation when incubated with atorvastatin or gemfibrozil. As a conlusion, both drugs showed similar effects on corpus cavernosum tissues. Atorvastatin and gemfibrozil caused these effects via endothelial nitric oxide. When all the results are evaluated, not only the two drugs showed no unfavorable effects but also may have some beneficial effects on erectile functions.Keywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?Journal of Molecular and Cellular Cardiology, 2012
- Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in miceBrain Research, 2009
- Characterization of hypertriglyceridemia-induced erectile dysfunctionUrology, 2006
- Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanismsEuropean Journal of Pharmacology, 2004
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialThe Lancet, 2004
- Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculatureAtherosclerosis, 2003
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Gemfibrozil-induced impotenceThe Lancet, 1990
- Gemfibrozil-induced impotenceThe Lancet, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987